Overview
- Effective Jan. 1, Dr. Cliff Deveny will become CEO emeritus and a strategic adviser, remaining actively engaged through 2026.
- HATCo president Daryl Tol will serve as acting president and CEO while a national search for a permanent leader proceeds over several months.
- The leadership change follows HATCo’s Oct. 1 acquisition that shifted Summa from nonprofit status to a taxable, for‑profit health system.
- Deal proceeds and pledged capital are slated to retire about $850 million in debt and support roughly $350 million for technology, $200 million for strategic transformation and $15 million for community health.
- Ohio regulators approved the conversion with conditions including community representation on the board and commitments on services and charity care, as local groups question the valuation and potential impacts on access and quality.